REUTERS: Britain's GSK said on Wednesday it expects full-year adjusted earnings to be at the lower end of its forecast as the COVID-19 pandemic disrupts vaccination rates, especially for its blockbuster shingles vaccine.
The world's largest vaccine maker now expects 2020 profit to be at the lower end of its forecast of a 1per cent-4per cent drop, which did not include any potential impact from the coronavirus crisis.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Fonte: ChannelNewsAsia - 🏆 6. / 66 Consulte Mais informação »